Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT00697658
Eligibility Criteria:
Inclusion Criteria:
* Patient meets the DSM-IV criteria for schizophrenia
* Switched to or started on paliperidone ER, not longer than two weeks ago
* In 24 hours before initiation of paliperidone ER treatment, CGI-S, patient satisfaction with treatment, concomitant therapy, body weight, GAF and HoNOS data are available
* Patient or legal representative has signed the informed consent form within two weeks after starting treatment with paliperidone ER
Exclusion Criteria:
* No use of paliperidone ER, clozapine, any conventional depot neuroleptic or long acting atypical antipsychotic drugs during 3 months before starting paliperidone ER
* No participation in an investigational drug trial in 30 days prior to starting paliperidone ER
* No history of neuroleptic malignant syndrome
* No known hypersensitivity to paliperidone ER or risperidone
* No patients hospitalized for a period longer than 12 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00697658
Study Brief:
Protocol Section:
NCT00697658